Table 2. Association of MCT1, MCT2, MCT4 and CD147 expression with clinicopathological parameters.

	MCT1		MCT2			MCT4			CD147
	n	Positive (%)	p	n	Positive (%)	p	n	Positive (%)	p	n	Positive (%)	p
T stage			0.148			0.081*			0.004			0.069*
T1	85	35 (41.2)		85	5 (5.9)		83	29 (34.9)		82	25 (30.5)
T2+T3+T4	58	31 (53.4)		58	0 (0.0)		57	34 (59.6)		57	26 (45.6)
N stage			0.015			1.000*			0.094			0.022*
N0	84	33 (39.3)		83	4 (4.8)		81	33 (40.7)		80	23 (28.8)
N1+N2+N3	62	37 (59.7)		62	2 (3.2)		62	34 (54.8)		60	29 (47.5)
M stage			0.002			1.000*			0.037			0.020*
M0	122	52 (42.6)		121	5 (4.1)		120	52(43.3)		118	39 (33.1)
M1	25	19 (76.0)		25	1 (4.0)		24	16(66.7)		24	14 (58.3)
Stage			0.001			1.000*			0.045			0.003*
I	74	26 (35.1)		73	3 (4.1)		72	28 (38.9)		71	18 (25.4)
IS+II+III+IV	73	45 (61.6)		73	3 (4.1)		72	40 (55.6)		71	35 (49.3)
Vascular invasion			0.889			0.178*			0.002			0.493*
No	99	45 (45.5)		99	6 (6.1)		97	35 (36.1)		96	33 (34.4)
Yes	43	19 (44.2)		43	0 (0.0)		42	27 (64.3)		42	17 (40.5)
Histology			<0.001			0.114*			<0.001			<0.001*
Seminoma	75	17 (22.7)		75	1 (1.3)		73	23 (31.5)		73	10 (13.7)
Nonseminomatous	74	54 (73.0)		73	5 (6.8)		73	46 (63.0)		71	43 (60.6)
IGCCG Risk			0.194*			0.452*			0.030*			0.801*
Low	45	26 (57.8)		45	2 (4.4)		45	21 (46.7)		44	22 (50.0)
Intermediate	11	7 (63.6)		11	0 (0.0)		11	8 (72.7)		11	7 (63.6)
High	10	9(90.0)		10	1(10.0)		9	8(88.9)		9	5 (55.6)
Recurrence			0.108			0.542*			0.303			0.682*
No	125	55 (44.0)		125	5 (4.0)		123	56 (45.5)		122	44 (36.1)
Yes	17	11 (64.7)		17	1 (5.9)		17	10 (58.8)		17	7 (41.2)
Progression			0.468*			0.287*			0.725*			1.000*
No	68	40 (58.8)		68	2 (2.9)		68	37 (54.4)		67	31 (46.3)
Yes	8	6 (75.0)		8	1 (12.5)		8	5 (62.5)		8	4 (50.0)

^*Fisher’s exact test.